Perioperative Cardiac Risk Stratification and Modification in Abdominal Aortic Aneurysm Repair
暂无分享,去创建一个
Jeroen J. Bax | H. Feringa | S. Hoeks | E. Boersma | D. Poldermans | P. Noordzij | O. Schouten | M. Dunkelgrun
[1] Jeroen J. Bax,et al. Prognostic value of routine preoperative electrocardiography in patients undergoing noncardiac surgery. , 2006, The American journal of cardiology.
[2] Jeroen J. Bax,et al. Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. , 2005, The American journal of medicine.
[3] H. Yeh,et al. Preoperative plasma N‐terminal pro‐brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non‐cardiac surgery , 2005, The British journal of surgery.
[4] P. Lindenauer,et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. , 2005, The New England journal of medicine.
[5] Gordon H Guyatt,et al. How strong is the evidence for the use of perioperative β blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials , 2005, BMJ : British Medical Journal.
[6] Roger M. Greenhalgh,et al. Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. , 2005, Lancet.
[7] B. Caramelli,et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. , 2005, Journal of vascular surgery.
[8] J. Ioannidis,et al. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. , 2005, Journal of the American College of Cardiology.
[9] Thomas E. Moritz,et al. Coronary-artery revascularization before elective major vascular surgery. , 2004, The New England journal of medicine.
[10] Jeroen J. Bax,et al. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study. , 2004, American heart journal.
[11] M. Sabatine,et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. , 2004, Journal of the American College of Cardiology.
[12] P. Lindenauer,et al. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery , 2004, JAMA.
[13] Jeroen J. Bax,et al. Aortic stenosis: an underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery. , 2004, The American journal of medicine.
[14] R. Stevens,et al. Pharmacologic Myocardial Protection in Patients Undergoing Noncardiac Surgery: A Quantitative Systematic Review , 2003, Anesthesia and analgesia.
[15] Jeroen J. Bax,et al. Statins Are Associated With a Reduced Incidence of Perioperative Mortality in Patients Undergoing Major Noncardiac Vascular Surgery , 2003, Circulation.
[16] E. Antman,et al. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery—Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluati , 2002, Journal of the American College of Cardiology.
[17] L. Goldman,et al. beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review. , 2002, JAMA.
[18] I. Kamae,et al. Efficacy of Clonidine for Prevention of Perioperative Myocardial Ischemia: A Critical Appraisal and Meta-analysis of the Literature , 2002, Anesthesiology.
[19] Jeroen J. Bax,et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. , 1999, The New England journal of medicine.
[20] L. Goldman,et al. Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). , 1999, Anesthesiology.
[21] E F Cook,et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. , 1999, Circulation.
[22] Farris K. Timimi,et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. , 1999, Anesthesia and analgesia.
[23] A. Wallace,et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. , 1996, The New England journal of medicine.
[24] Allan S. Detsky,et al. Predicting cardiac complications in patients undergoing non-cardiac surgery , 1986, Journal of General Internal Medicine.
[25] N. Hertzer,et al. Coronary Artery Disease in Peripheral Vascular Patients: A Classification of 1000 Coronary Angiograms and Results of Surgical Management , 1984, Annals of surgery.
[26] L Goldman,et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. , 1977, The New England journal of medicine.
[27] M. Sydes,et al. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. , 2005, Journal of vascular surgery.
[28] Jeroen J. Bax,et al. Comparison between serum creatinine and creatinine clearance for the prediction of postoperative mortality in patients undergoing major vascular surgery. , 2003, Clinical nephrology.